82 FR 10370 - National Heart, Lung, and Blood Institute; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 82, Issue 27 (February 10, 2017)

Page Range		10370-10370
FR Document		2017-02723

Federal Register, Volume 82 Issue 27 (Friday, February 10, 2017)

[Federal Register Volume 82, Number 27 (Friday, February 10, 2017)]
[Notices]
[Page 10370]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-02723]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Heart, Lung, and Blood Institute; Notice of Closed 
Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Heart, Lung, and Blood Institute 
Special Emphasis Panel; NHLBI CLTR SEP Review.
    Date: March 3, 2017.
    Time: 8:00 a.m. to 3:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Courtyard by Marriott, 5520 Wisconsin Avenue, Chevy 
Chase, MD 20815.
    Contact Person: Chang Sook Kim, Ph.D., Scientific Review 
Officer, Office of Scientific Review/DERA, National Heart, Lung, and 
Blood Institute, 6701 Rockledge Drive, Room 7188, Bethesda, MD 
20892-7924, 301-827-7940, [email protected].

    Name of Committee: National Heart, Lung, and Blood Institute 
Special Emphasis Panel; Career Development Program to Promote 
Diversity in Health Research.
    Date: March 3, 2017.
    Time: 8:30 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda, 
MD 20814.
    Contact Person: YingYing Li-Smerin, MD, Ph.D., Scientific Review 
Officer, Office of Scientific Review/DERA, National Heart, Lung, and 
Blood Institute, 6701 Rockledge Drive, Room 7184, Bethesda, MD 
20892-7924, 301-827-7942, [email protected].

    Name of Committee: National Heart, Lung, and Blood Institute 
Special Emphasis Panel; Cystic Fibrosis Transmembrane Conductance 
Regulator--Directed Therapeutics.
    Date: March 3, 2017.
    Time: 2:00 p.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Rockledge Two, 7185, 6701 
Rockledge Drive, Bethesda, MD 20892 (Telephone Conference Call).
    Contact Person: Kristen Page, Ph.D., Scientific Review Officer, 
Office of Scientific Review/DERA, National Heart, Lung, and Blood 
Institute, National Institutes of Health, 6701 Rockledge Drive, Room 
7185, Bethesda, MD 20892, 301-827-7953, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.233, 
National Center for Sleep Disorders Research; 93.837, Heart and 
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839, 
Blood Diseases and Resources Research, National Institutes of 
Health, HHS)

    Dated: February 6, 2017.
Michelle Trout,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-02723 Filed 2-9-17; 8:45 am]
BILLING CODE 4140-01-P

10370 Federal Register / Vol. 82, No. 27 / Friday, February 10, 2017 / Notices

regard to whether the countermeasure is Covered Countermeasures obtained and personal information concerning
used by or administered to this for the Strategic Nations Stockpile (SNS) individuals associated with the grant
population; liability immunity is during the effective period of this applications, the disclosure of which
afforded to program planners and Declaration are covered through the date would constitute a clearly unwarranted
qualified persons when the of administration or use pursuant to a invasion of personal privacy.
countermeasure is used by or distribution or release from the SNS. Name of Committee: National Heart, Lung,
administered to this population, or the and Blood Institute Special Emphasis Panel;
XIV. Countermeasures Injury
program planner or qualified person NHLBI CLTR SEP Review.
reasonably could have believed the Compensation Program
Date: March 3, 2017.
recipient was in this population. 42 U.S.C 247d–6e Time: 8:00 a.m. to 3:00 p.m.
XI. Geographic Area The PREP Act authorizes the Agenda: To review and evaluate grant
Countermeasures Injury Compensation applications.
42 U.S.C. 247d–6d(a)(4), 247d– Program (CICP) to provide benefits to Place: Courtyard by Marriott, 5520
6d(b)(2)(D) certain individuals or estates of Wisconsin Avenue, Chevy Chase, MD 20815.
Liability immunity is afforded for the individuals who sustain a covered Contact Person: Chang Sook Kim, Ph.D.,
administration or use of a Covered serious physical injury as the direct Scientific Review Officer, Office of Scientific
Countermeasure without geographic result of the administration or use of the Review/DERA, National Heart, Lung, and
limitation. Covered Countermeasures, and benefits Blood Institute, 6701 Rockledge Drive, Room
Liability immunity is afforded to to certain survivors of individuals who 7188, Bethesda, MD 20892–7924, 301–827–
manufacturers and distributors without die as a direct result of the 7940, carolko@mail.nih.gov.
regard to whether the countermeasure is administration or use of the Covered Name of Committee: National Heart, Lung,
used by or administered in any Countermeasures. The causal and Blood Institute Special Emphasis Panel;
designated geographic area; liability connection between the countermeasure Career Development Program to Promote
immunity is afforded to program and the serious physical injury must be Diversity in Health Research.
planners and qualified persons when supported by compelling, reliable, valid, Date: March 3, 2017.
the countermeasure is used by or medical and scientific evidence in order Time: 8:30 a.m. to 5:00 p.m.
administered in any designated for the individual to be considered for Agenda: To review and evaluate grant
geographic area, or the program planner compensation. The CICP is applications.
or qualified person reasonably could administered by the Health Resources Place: Residence Inn Bethesda, 7335
have believed the recipient was in that Wisconsin Avenue, Bethesda, MD 20814.
and Services Administration, within the
geographic area. Contact Person: YingYing Li-Smerin, MD,
Department of Health and Human
Ph.D., Scientific Review Officer, Office of
XII. Effective Time Period Services. Information about the CICP is
Scientific Review/DERA, National Heart,
available at the toll-free number 1–855–
42 U.S.C. 247d–6d(b)(2)(B) Lung, and Blood Institute, 6701 Rockledge
266–2427 or http://www.hrsa.gov/cicp/. Drive, Room 7184, Bethesda, MD 20892–
Liability immunity for Covered
XV. Amendments 7924, 301–827–7942, lismerin@nhlbi.nih.gov.
Countermeasures through means of
distribution, as identified in Section 42 U.S.C. 247d–6d(b)(4) Name of Committee: National Heart, Lung,
VII(a) of this Declaration, other than in and Blood Institute Special Emphasis Panel;
Amendments to this Declaration will Cystic Fibrosis Transmembrane Conductance
accordance with the public health and be published in the Federal Register. Regulator—Directed Therapeutics.
medical response of the Authority
Authority: 42 U.S.C. 247d–6d. Date: March 3, 2017.
Having Jurisdiction and extends for 24
Time: 2:00 p.m. to 5:00 p.m.
months from the effective date of this Dated: February 6, 2017.
Agenda: To review and evaluate grant
Declaration. Norris Cochran,
applications.
Liability immunity for Covered Acting Secretary of Health and Human Place: National Institutes of Health,
Countermeasures administered and Services.
Rockledge Two, 7185, 6701 Rockledge Drive,
used in accordance with the public [FR Doc. 2017–02778 Filed 2–9–17; 8:45 am] Bethesda, MD 20892 (Telephone Conference
health and medical response of the BILLING CODE 4150–28–P Call).
Authority Having Jurisdiction begins
Contact Person: Kristen Page, Ph.D.,
with a Declaration and lasts through (1) Scientific Review Officer, Office of Scientific
the final day the emergency Declaration DEPARTMENT OF HEALTH AND Review/DERA, National Heart, Lung, and
is in effect, or (2) 24 months from the HUMAN SERVICES Blood Institute, National Institutes of Health,
effective date of this Declaration, 6701 Rockledge Drive, Room 7185, Bethesda,
whichever occurs first. National Institutes of Health MD 20892, 301–827–7953, kristen.page@
XIII. Additional Time Period of nih.gov.
National Heart, Lung, and Blood
Coverage Institute; Notice of Closed Meetings (Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
42 U.S.C. 247d–6d(b)(3)(B) and (C) Pursuant to section 10(d) of the Sleep Disorders Research; 93.837, Heart and
I have determined that an additional Federal Advisory Committee Act, as Vascular Diseases Research; 93.838, Lung
12 months of liability protection is amended (5 U.S.C. App.), notice is Diseases Research; 93.839, Blood Diseases
reasonable to allow for the hereby given of the following meetings. and Resources Research, National Institutes
manufacturer(s) to arrange for The meetings will be closed to the
mstockstill on DSK3G9T082PROD with NOTICES

of Health, HHS)
disposition of the Covered public in accordance with the
Dated: February 6, 2017.
Countermeasure, including return of the provisions set forth in sections
Covered Countermeasures to the 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Michelle Trout,
manufacturer, and for Covered Persons as amended. The grant applications and Program Analyst, Office of Federal Advisory
to take such other actions as are the discussions could disclose Committee Policy.
appropriate to limit the administration confidential trade secrets or commercial [FR Doc. 2017–02723 Filed 2–9–17; 8:45 am]
or use of the Covered Countermeasures. property such as patentable material, BILLING CODE 4140–01–P

VerDate Sep<11>2014 18:35 Feb 09, 2017 Jkt 241001 PO 00000 Frm 00043 Fmt 4703 Sfmt 9990 E:\FR\FM\10FEN1.SGM 10FEN1

Document Created: 2017-02-11 18:15:03
Document Modified: 2017-02-11 18:15:03

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		March 3, 2017.
FR Citation		82 FR 10370

82 FR 10370 - National Heart, Lung, and Blood Institute; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 82, Issue 27 (February 10, 2017)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health